AMRX

Amneal Pharmaceuticals, Inc.

Healthcare›Drug Manufacturers - Specialty & Generic|NASDAQ Global Select|US

Price

$12.48

Market Cap

$3.93B

Beta

1.32

P/E

56.6

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+8.05%

EPS Growth (YoY)+158.84%

Revenue CAGR 3Y+10.92%

P/E Ratio56.6

PEG Ratio0.35

FCF Yield+6.03%

Debt / Equity0.00

Interest Coverage1.4x

No credit card required

Already have an account? Sign in to view the full analysis for AMRX.